Take Willows free online assessment to see if you qualify for GLP-1 treatment
Wegovy and Ozempic, Novo Nordisk's drug approved for diabetes, are the same medication, while Zepbound is almost the same as Mounjaro, Eli Lilly's diabetes medication
It is still too early to draw definitive conclusions, but the numerous ongoing clinical trials, including the cardiovascular safety trial versus an active comparator (dulaglutide), the first of its kind, will provide us shortly with important confirmations
This guide explains how to access GLP-1 medications cost-effectively, eligibility criteria for NHS prescriptions, and factors affecting overall treatment expenses, helping you make informed decisions about affordable diabetes and weight management care